184 related articles for article (PubMed ID: 36552904)
1. A Pilot Analysis of Circulating cfRNA Transcripts for the Detection of Lung Cancer.
Seneviratne C; Shetty AC; Geng X; McCracken C; Cornell J; Mullins K; Jiang F; Stass S
Diagnostics (Basel); 2022 Nov; 12(12):. PubMed ID: 36552904
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of circulating cell-free RNAs in blood for diagnosing non-small cell lung cancer.
Liu Y; Liang Y; Li Q; Li Q
Comput Struct Biotechnol J; 2023; 21():4238-4251. PubMed ID: 37692082
[TBL] [Abstract][Full Text] [Related]
3. Proof of concept: Detection of cell free RNA from EDTA plasma in patients with lung cancer and non-cancer patients.
Mullins KE; Seneviratne C; Shetty AC; Jiang F; Christenson R; Stass S
Clin Biochem; 2023 Aug; 118():110583. PubMed ID: 37182637
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
[TBL] [Abstract][Full Text] [Related]
5. Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer.
Metzenmacher M; Váraljai R; Hegedüs B; Cima I; Forster J; Schramm A; Scheffler B; Horn PA; Klein CA; Szarvas T; Reis H; Bielefeld N; Roesch A; Aigner C; Kunzmann V; Wiesweg M; Siveke JT; Schuler M; Lueong SS
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32033141
[TBL] [Abstract][Full Text] [Related]
6. Terminal modifications independent cell-free RNA sequencing enables sensitive early cancer detection and classification.
Wang J; Huang J; Hu Y; Guo Q; Zhang S; Tian J; Niu Y; Ji L; Xu Y; Tang P; He Y; Wang Y; Zhang S; Yang H; Kang K; Chen X; Li X; Yang M; Gou D
Nat Commun; 2024 Jan; 15(1):156. PubMed ID: 38168054
[TBL] [Abstract][Full Text] [Related]
7. Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype.
Albrecht LJ; Höwner A; Griewank K; Lueong SS; von Neuhoff N; Horn PA; Sucker A; Paschen A; Livingstone E; Ugurel S; Zimmer L; Horn S; Siveke JT; Schadendorf D; Váraljai R; Roesch A
Clin Transl Med; 2022 Nov; 12(11):e1090. PubMed ID: 36320118
[TBL] [Abstract][Full Text] [Related]
8. The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non-small cell lung cancer.
Metzenmacher M; Hegedüs B; Forster J; Schramm A; Horn PA; Klein CA; Bielefeld N; Ploenes T; Aigner C; Siveke JT; Schuler M; Lueong SS
Thorac Cancer; 2022 Aug; 13(15):2180-2191. PubMed ID: 35708207
[TBL] [Abstract][Full Text] [Related]
9. A Multiplex Thyroid-Specific Assay for Quantification of Circulating Thyroid Cell-Free RNA in Plasma of Thyroid Cancer Patients.
Yang SP; Koh LCW; Kong KW; Parameswaran R; Loke KSH; Ngiam KY; Tan WB; Loh T; Ng DCE; Goh BC; Ngeow J; Tai ES
Front Genet; 2021; 12():721832. PubMed ID: 34512731
[TBL] [Abstract][Full Text] [Related]
10. Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers.
Hasegawa N; Kohsaka S; Kurokawa K; Shinno Y; Takeda Nakamura I; Ueno T; Kojima S; Kawazu M; Suehara Y; Ishijima M; Goto Y; Kojima Y; Yonemori K; Hayashi T; Saito T; Shukuya T; Takahashi F; Takahashi K; Mano H
Cancer Sci; 2021 Oct; 112(10):4393-4403. PubMed ID: 34310819
[TBL] [Abstract][Full Text] [Related]
11. Using cfRNA as a tool to evaluate clinical treatment outcomes in patients with metastatic lung cancers and other tumors.
Raez LE; Danenberg K; Sumarriva D; Usher J; Sands J; Castrellon A; Ferraro P; Milillo A; Huang E; Soon-Shiong P; Reddy S; Danenberg P
Cancer Drug Resist; 2021; 4(4):1061-1071. PubMed ID: 35582387
[No Abstract] [Full Text] [Related]
12. Evaluating the Effects of Storage Conditions on Multiple Cell-Free RNAs in Plasma by High-Throughput Sequencing.
Sun J; Yang X; Wang T; Xing Y; Chen H; Zhu S; Zeng J; Zhou Q; Chen F; Zhang X; Wang WJ
Biopreserv Biobank; 2023 Jun; 21(3):242-254. PubMed ID: 36006659
[No Abstract] [Full Text] [Related]
13. Method for the extraction of circulating nucleic acids based on MOF reveals cell-free RNA signatures in liver cancer.
Sun Y; Yu H; Han S; Ran R; Yang Y; Tang Y; Wang Y; Zhang W; Tang H; Fu B; Fu B; Weng X; Liu SM; Deng H; Peng S; Zhou X
Natl Sci Rev; 2024 Jan; 11(1):nwae022. PubMed ID: 38348130
[TBL] [Abstract][Full Text] [Related]
14. Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies.
Roskams-Hieter B; Kim HJ; Anur P; Wagner JT; Callahan R; Spiliotopoulos E; Kirschbaum CW; Civitci F; Spellman PT; Thompson RF; Farsad K; Naugler WE; Ngo TTM
NPJ Precis Oncol; 2022 Apr; 6(1):28. PubMed ID: 35468987
[TBL] [Abstract][Full Text] [Related]
15. Cell-free circulating tumor RNAs in plasma as the potential prognostic biomarkers in colorectal cancer.
Jin N; Kan CM; Pei XM; Cheung WL; Ng SSM; Wong HT; Cheng HY; Leung WW; Wong YN; Tsang HF; Chan AKC; Wong YKE; Cho WCS; Chan JKC; Tai WCS; Chan TF; Wong SCC; Yim AK; Yu AC
Front Oncol; 2023; 13():1134445. PubMed ID: 37091184
[TBL] [Abstract][Full Text] [Related]
16. Cell-Free RNA as a Novel Biomarker for Response to Therapy in Head & Neck Cancer.
Tosevska A; Morselli M; Basak SK; Avila L; Mehta P; Wang MB; Srivatsan ES; Pellegrini M
Front Oncol; 2022; 12():869108. PubMed ID: 35600369
[TBL] [Abstract][Full Text] [Related]
17. cfRNAs as biomarkers in oncology - still experimental or applied tool for personalized medicine already?
Kolenda T; Guglas K; Baranowski D; Sobocińska J; Kopczyńska M; Teresiak A; Bliźniak R; Lamperska K
Rep Pract Oncol Radiother; 2020; 25(5):783-792. PubMed ID: 32904167
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Review on Circulating cfRNA in Plasma: Implications for Disease Diagnosis and Beyond.
Zhong P; Bai L; Hong M; Ouyang J; Wang R; Zhang X; Chen P
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786343
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection.
Larson MH; Pan W; Kim HJ; Mauntz RE; Stuart SM; Pimentel M; Zhou Y; Knudsgaard P; Demas V; Aravanis AM; Jamshidi A
Nat Commun; 2021 Apr; 12(1):2357. PubMed ID: 33883548
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic role of liquid biopsy in non-small cell lung cancer: evaluation of circulating biomarkers.
Vicidomini G; Cascone R; Carlucci A; Fiorelli A; Di Domenico M; Santini M
Explor Target Antitumor Ther; 2020; 1(5):343-354. PubMed ID: 36046486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
